EXPOSURE-RESPONSE ANALYSIS OF ESLICARBAZEPINE ACETATE ADJUNCTIVE TREATMENT OF PATIENTS WITH PARTIAL-ONSET SEIZURES

被引：0
|
作者：
Passarell, J. [1 ]
Kharidia, J. [2 ]
Maier, G. [2 ]
Ludwig, E. [1 ]
Grasela, T. [1 ]
Fiedler-Kelly, J. [1 ]
机构：
[1] Cognigen Corp, Buffalo, NY USA
[2] Sepracor Inc, Marlborough, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [41] Perampanel As Adjunctive Therapy in Patients with Partial-Onset Seizures
    Plosker, Greg L.
    CNS DRUGS, 2012, 26 (12) : 1085 - 1096
  • [42] Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures
    Schoemaker, Rik
    Wade, Janet R.
    Stockis, Armel
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1591 - 1602
  • [43] Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures
    Soujanya Sunkaraneni
    Elizabeth Ludwig
    Jill Fiedler-Kelly
    Seth Hopkins
    Gerald Galluppi
    David Blum
    Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 649 - 658
  • [44] TIME OF OCCURRENCE OF ADVERSE EVENTS IN RELATION TO START OF TREATMENT WITH ESLICARBAZEPINE ACETATE AS ADD-ON TREATMENT IN PATIENTS WITH PARTIAL-ONSET SEIZURES
    Gama, H.
    Elger, C.
    Halasz, P.
    Ben-Menachem, E.
    Alain-Gabbai, A.
    Lopes-Lima, J.
    Gil-Nagel, A.
    Nunes, T.
    Moreira, J.
    Mota, F.
    Maia, J.
    Almeida, L.
    Soares-da-Silva, P.
    EPILEPSIA, 2009, 50 : 63 - 63
  • [45] Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures
    Sunkaraneni, Soujanya
    Ludwig, Elizabeth
    Fiedler-Kelly, Jill
    Hopkins, Seth
    Galluppi, Gerald
    Blum, David
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 (04) : 649 - 658
  • [46] Tolerability of Adjunctive Eslicarbazepine Acetate (ESL) in Elderly Patients with Partial-Onset Seizures (POS): An Exploratory Post-Hoc Analysis of Three Phase III Studies
    Rosenfeld, William
    Penovich, Patricia
    Rogin, Joanne
    Cendes, Fernando
    Carreno, Mar
    Gama, Helena
    Rocha, Francisco
    Tosiello, Robert
    Blum, David
    Grinnell, Todd
    NEUROLOGY, 2016, 86
  • [47] Long-term adjunctive lacosamide treatment in patients with partial-onset seizures
    Rosenow, F.
    Kelemen, A.
    Ben-Menachem, E.
    McShea, C.
    Isojarvi, J.
    Doty, P.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (02): : 136 - 144
  • [48] THE DESIGN OF A PHASE III CLINICAL STUDY OF ESLICARBAZEPINE ACETATE IN ELDERLY PATIENTS WITH PARTIAL-ONSET SEIZURES IN EPILEPSY
    Nunes, T.
    Steinhoff, B. J.
    Costa, R.
    Pinto, R.
    Lopes, N.
    Soares-da-Silva, P.
    EPILEPSIA, 2011, 52 : 110 - 110
  • [49] Lacosamide: new adjunctive treatment option for partial-onset seizures
    Chung, Steve S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (09) : 1595 - 1602
  • [50] Safety and Tolerability of Adjunctive Eslicarbazepine Acetate (ESL) in Pediatric Patients (Aged 4-17 Years) with Partial-Onset (Focal) Seizures (POS)
    Mintz, Mark
    Pina-Garza, Jesus
    Wolf, Steven
    McGoldrick, Patricia
    Grinnell, Todd
    Cantu, David
    Costa, Raquel
    Moreira, Joana
    Li, Yan
    Jozwiak, Sergiusz
    Blum, David
    NEUROLOGY, 2018, 90
12345